Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Annals of the New York Academy of Sciences|August 12, 1993
Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvantB M Longenecker, M Reddish, R Koganty, et al.
Biochemical and Biophysical Research Communications|July 17, 2001
Association of MUC-1 and SPGL-1 with low-density microdomain in T-lymphocytes: a preliminary noteK Handa, F Jacobs, B M Longenecker, et al.
Current Opinion in Hematology|January 1, 1996
Stress- and mitogen-activated signal transduction in hematopoietic cellsM W Kieran, L I Zon
Current Opinion in Pediatrics|March 20, 1999
Innovative therapies for pediatric brain tumorsJ B Rubin, M W Kieran
International Immunology|January 14, 1999
Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopesB Agrawal, M J Krantz, M A Reddish, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|February 1, 2003
Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigenJ Schuman, A P Campbell, R R Koganty, et al.
Nature Medicine|January 14, 1998
Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2B Agrawal, M J Krantz, M A Reddish, et al.
Pageof 12